New At-Home test could detect flu and COVID in minutes

NCT ID NCT07430410

Not yet recruiting Diagnosis Sponsor: CorDx, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new at-home rapid test that checks for flu A, flu B, and COVID-19 using a nasal swab. About 200 people with symptoms will use the test themselves, and their results will be compared to standard lab PCR tests. The goal is to see if the test is accurate and easy for people to use without training.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CorDx Tyfast Flu A/B & COVID-19 At-Home Multiplex Rapid Test (a device for detecting viral antigens from a nasal swab)
What this could lead to: If successful, this could provide a reliable at-home test for flu and COVID-19, making it easier for people to quickly know what they have and seek appropriate care.
What could go wrong: This is an early-stage validation study with only 200 participants. The test may not be as accurate as lab tests, and results could vary with different users or virus strains.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 influenza swine influenza

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLUENZA A INFLUENZA B SARS-COV-2 INFECTION

More trials for these conditions

Other studies related to the condition(s) this trial covers.